New York State Common Retirement Fund’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.1K Hold
8,497
﹤0.01% 2951
2026
Q1
$65.6K Hold
8,497
﹤0.01% 2722
2025
Q4
$52.1K Hold
8,497
﹤0.01% 2891
2025
Q3
$157K Hold
8,497
﹤0.01% 2409
2025
Q2
$111K Hold
8,497
﹤0.01% 2519
2025
Q1
$90K Sell
8,497
-1,100
-11% -$17.5K ﹤0.01% 2566
2024
Q4
$163K Hold
9,597
﹤0.01% 2392
2024
Q3
$223K Hold
9,597
﹤0.01% 2240
2024
Q2
$234K Buy
9,597
+20
+0.2% +$606 ﹤0.01% 2360
2024
Q1
$323K Sell
9,577
-27
-0.3% -$957 ﹤0.01% 2251
2023
Q4
$303K Sell
9,604
-42
-0.4% -$998 ﹤0.01% 2285
2023
Q3
$246K Buy
9,646
+72
+0.8% +$2.22K ﹤0.01% 2333
2023
Q2
$275K Sell
9,574
-5,726
-37% -$156K ﹤0.01% 2359
2023
Q1
$367K Hold
15,300
﹤0.01% 2332
2022
Q4
$259K Sell
15,300
-9
-0.1% -$157 ﹤0.01% 2614
2022
Q3
$227K Buy
15,309
+49
+0.3% +$822 ﹤0.01% 2719
2022
Q2
$240K Sell
15,260
-14
-0.1% -$275 ﹤0.01% 2711
2022
Q1
$412K Sell
15,274
-5
-0% -$128 ﹤0.01% 2492
2021
Q4
$565K Sell
15,279
-35
-0.2% -$1.43K ﹤0.01% 2373
2021
Q3
$732K Sell
15,314
-2,554
-14% -$114K ﹤0.01% 2255
2021
Q2
$605K Sell
17,868
-932
-5% -$31.6K ﹤0.01% 2493
2021
Q1
$776K Sell
18,800
-1,100
-6% -$65.6K ﹤0.01% 2240
2020
Q4
$863K Buy
19,900
+7,900
+66% +$535K ﹤0.01% 2101
2020
Q3
$515K Hold
12,000
﹤0.01% 2194
2020
Q2
$561K Buy
+12,000
New +$414K ﹤0.01% 2146

Other funds holding ARCT

New York State Common Retirement Fund's ARCT Position: Q2 2026 in Review

New York State Common Retirement Fund held its Arcturus Therapeutics (ARCT) position steady in Q2 2026 at 8,497 shares worth $57.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2951.

New York State Common Retirement Fund first reported a position in ARCT in Q2 2020 and has held it in 25 quarters since. The position peaked at $863K in Q4 2020. 32 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • New York State Common Retirement Fund held 8,497 shares of Arcturus Therapeutics worth $57.1K as of Q2 2026.
  • New York State Common Retirement Fund left its Arcturus Therapeutics share count unchanged in Q2 2026.
  • Arcturus Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2951 holding.
  • New York State Common Retirement Fund first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • New York State Common Retirement Fund's Arcturus Therapeutics position peaked at $863K in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.